| Financial Year |
March 31 2023 |
| Monetary Funds |
272,040,963.62 |
| Held-for-trading Financial Assets |
562,998,728.42 |
| Notes Receivable |
2,899,580.99 |
| Accounts Receivable |
24,458,928.08 |
| Advances to Suppliers |
9,567,864.28 |
| Other Receivables |
1,748,494.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
210,561,179.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,203,237.81 |
| Total Current Assets |
1,103,083,335.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
29,617,130.43 |
| Investment Properties |
207,088,830.17 |
| Fixed Assetes |
194,447,328.51 |
| Under-construction Projects |
4,195,908.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,724,016.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,834,471.51 |
| Deferred Income Tax Assets |
7,456,075.26 |
| Other Non-Current Assets |
32,050.00 |
| Sub-Total of Non-Current Assets |
560,376,723.05 |
| Total Assets |
1,663,460,058.84 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
12,718,962.65 |
| Accounts Received In Advance |
11,194,092.27 |
| Employee Compensation Payable |
6,641,098.20 |
| Taxes Payable |
2,889,470.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,273,355.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
503,465.40 |
| Other Current Liabilities |
7,767,449.81 |
| Sub-Total of Current Liabilities |
124,067,058.66 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
786,380.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,676,148.93 |
| Total Liabilities |
130,743,207.59 |
| Paid-In Capital(Or Share Stock) |
268,958,778.00 |
| Capital Surplus |
969,210,315.19 |
| Surplus Reserve |
67,038,104.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
220,159,920.91 |
| Minority Stockholder's Interest |
12,804,978.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,519,911,872.46 |
| Owner's Equity（Stockholder's Equity） |
1,532,716,851.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,663,460,058.84 |
